Analysis of:
Datacsope stock soars on takeover tlaks (www.northjersey.com)
-Datascope has decided to exit the monitor market by selling a chunk of itself off, possibly making itself into a takeover candidate. The remaining units make stents, balloon catheters and other cardiac equipment. -One other effect is that it has placed itself into direct (rather than indirect)...
Analysis of:
Novartis presents full pipeline of novel vaccines addressing significant unmet needs (www.pipelinereview.com)
-Novartis' press conference discussed a "full pipline" of new vaccines, but the majority are still Phase I. -The meningitis vaccines being developed are not yet ready to go, and the one that is closest to being filed already has a competitor on the market.
Analysis of:
GlaxoSmithKline given OK to sell bird-flu vaccine in Europe (www.bizjournals.com)
Whether or not the bird flu ever becomes a threat to humans, Glaxo has won here. Since it will be impossible to rule out a serious risk of epidemics, an effective vaccine will have to be purchased and stockpiled by governments and other health care systems.
Analysis of:
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six (www.pipelinereview.com)
Symbicort has proven safe and effective in ages 12 and up, and should confer its benefits on younger patients as well.
Analysis of:
Novartis presents full pipeline of novel vaccines addressing significant unmet needs (www.pipelinereview.com)
Novartis is developing vaccines for diseases for which there are no current products available. Group B Strep, N. meningitidis Group B and H. Pylori are all common pathogens and cause significant morbidity.
Analysis of:
GlaxoSmithKline given OK to sell bird-flu vaccine in Europe (www.bizjournals.com)
-Glaxo's pre-pandemic flu vaccine is a double opportunity - a chance to contract now with multiple governments to supply a pre-pandemic vaccine as well as a natural segue to become their future supplier of actual pandemic flu vaccine (when developed). -When pandemic flu hits, the race will be...
Analysis of:
EU Approves GSK's Pre-Pandemic Bird Flu Vaccine (www.medicalnewstoday.com)
Glaxo's new pandemic flu vaccine was just approved for sale and use in the EU. It has or is trying to establish contracts with multiple countries to supply stockpiles with values in the 100's of millions
Analysis of:
Guidelines Issued for Treating Atopic Eczema in Children (www.medscape.com)
This article summarizes in a concise format what most of us do anyway. Nonetheless, it is good to have the steps clearly spelled out.
Analysis of:
Analyst: $850M opportunity for Allscripts with merger (www.forbes.com)
I'd go with the second analyst in the article, who points out the exosting product overlap between the two companies.
Analysis of:
Renal Failure Linked to Cosmetic Soft-Tissue Filler Injections (www.medscape.com)
The major effect, I would hope, would be to keep people from using unlicensed practitioners to do unapproved procedures with inappropriate products.